WO2003018629A8 - Cage antigen - Google Patents

Cage antigen

Info

Publication number
WO2003018629A8
WO2003018629A8 PCT/KR2002/001576 KR0201576W WO03018629A8 WO 2003018629 A8 WO2003018629 A8 WO 2003018629A8 KR 0201576 W KR0201576 W KR 0201576W WO 03018629 A8 WO03018629 A8 WO 03018629A8
Authority
WO
WIPO (PCT)
Prior art keywords
cage
antigen
various
dna
codes
Prior art date
Application number
PCT/KR2002/001576
Other languages
French (fr)
Other versions
WO2003018629A1 (en
Inventor
Dae-Kee Kim
Dooil Jeoung
Bomsoo Cho
Yoon Lim
Saeyoung Park
Daeyeon Lee
Yungjue Bang
Hankwang Yang
Original Assignee
In2Gen Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/195,117 external-priority patent/US20030092083A1/en
Application filed by In2Gen Co Ltd filed Critical In2Gen Co Ltd
Publication of WO2003018629A1 publication Critical patent/WO2003018629A1/en
Publication of WO2003018629A8 publication Critical patent/WO2003018629A8/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Abstract

This invention relates to an isolated CAGE gene, which codes for a novel cancer/testis antigen expressed in various cancer cells. Various diagnostic and therapeutic uses arising out of the properties of the DNA and protein are part of this invention.
PCT/KR2002/001576 2001-08-23 2002-08-20 Cage antigen WO2003018629A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR20010050836 2001-08-23
KR2001/50836 2001-08-23
US10/195,117 US20030092083A1 (en) 2001-08-23 2002-07-11 Cage antigen
US10/195,117 2002-07-11

Publications (2)

Publication Number Publication Date
WO2003018629A1 WO2003018629A1 (en) 2003-03-06
WO2003018629A8 true WO2003018629A8 (en) 2004-05-27

Family

ID=26639314

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2002/001576 WO2003018629A1 (en) 2001-08-23 2002-08-20 Cage antigen

Country Status (1)

Country Link
WO (1) WO2003018629A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100478509C (en) 2001-12-05 2009-04-15 休闲生活世界股份有限公司 Method for making furniture by using synthesized weaving material
FR2854903A1 (en) * 2003-05-13 2004-11-19 Centre Nat Rech Scient In vitro diagnosis of cancer, based on detecting hypomethylation of deoxycytidine in CpG doublets present in specific sequences from the B melanoma antigen locus
WO2008091873A2 (en) 2007-01-24 2008-07-31 Dana-Farber Cancer Institute, Inc. Compositions and methods for the identification, assessment, prevention and therapy of thymic lymphoma or hamartomatous tumours
JP5267969B2 (en) * 2007-12-04 2013-08-21 学校法人慶應義塾 Cancer vaccine
KR102073144B1 (en) * 2018-12-13 2020-02-04 주식회사 엘베이스 Pharmaceutical Composition for Preventing or Treating Cancer Comprising Oligopeptide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245525B1 (en) * 1998-07-27 2001-06-12 Ludwig Institute For Cancer Research Tumor associated nucleic acids and uses therefor

Also Published As

Publication number Publication date
WO2003018629A1 (en) 2003-03-06

Similar Documents

Publication Publication Date Title
WO2002092818A8 (en) Streptococcus agalactiae genome sequence, use for developing vaccines, diagnostic tools, and for identifying therapeutic targets
WO2002095051A3 (en) Mage-a3 peptides presented by hla class ii molecules
WO2003014303A3 (en) Molecular interactions in cells
WO2006028429A3 (en) Peptides for targeting the prostate specific membrane antigen
WO1998059040A3 (en) Human catalytic telomerase sub-unit and its diagnostic and therapeutic use
WO2005026205A3 (en) Genetic products which are differentially expressed in tumours and use thereof
WO2001046225A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2003018629A8 (en) Cage antigen
WO2004092212A3 (en) Tumor antigens bfa5 for prevention and/or treatment of cancer
WO2005033265A3 (en) Optimized multi-epitope constructs and uses thereof
WO2005013904A3 (en) Sars nucleic acids, proteins, vaccines, and uses thereof
WO2001059120A3 (en) Il-17 like molecules and uses thereof
PL374550A1 (en) Il-17 like molecules and uses thereof
WO2001027254A3 (en) Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy
WO2005049793A3 (en) Methods and compositions for combinatorial approaches to cancer gene therapy
WO2005023979A3 (en) Isolated s. mansoni nucleic acid molecules and uses thereof
WO2001031343A3 (en) Diagnosis and therapy of cancer using sgp28-related molecules
AU2001292326A1 (en) Nucleic acid of novel human kinesin-associated gene, protein encoded by the nucleic acid, peptide fragment thereof and anticancer agents comprising the nucleic acid and the like
WO2002044366A3 (en) Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379
WO2004053117A3 (en) Serine protease
WO2004076613A3 (en) Human nucleic acid sequences from carcinomas of the bladder
AU2002326318A1 (en) Targeting tumor cell antigens: antibodies useful for the diagnosis, prognosis, and treatment of cancer
WO2002063013A3 (en) Human acid phosphatase gene
EP1383871A4 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2001227570A1 (en) Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG UZ VC VN YU ZA ZM

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 10/2003 UNDER (72) ADD "JEOUNG, DOOIL; 7-1308 MISUNG APT., BULGWANG-DONG, EUNPYUNG-GU, 122-040 SEOUL (KR). CHO, BOMSOO; 604 HYUNDAI AHYUN APT., AHYUN 1-DONG, MAPO-GU, 121-011 SEOUL (KR). LIM, YOON; 95-58 SONGPA 1-DONG, SONGPA-GU, 138-850 SEOUL (KR). PARK, SAEYOUNG; 101 LOTTEGREEN MANSION, 69-43 DOWON-DONG, JUNG-GU, 400-140 INCHON (KR). LEE, DAEYEON; 7-708 DONGBU APT., 66-26 SONGHYUN 1-DONG, DONG-GU, 401-761 INCHON (KR). BANG, YUNGJUE; 120-604 HUYNDAI APT., 434 APGUJEONG-DONG, KANGNAM-GU, 135-110 SEOUL (KR). YANG, HANKWANG; 14-601 SAMHO APT., BANGBAE-DONG, SEOCHO-GU, 137-759 SEOUL (KR)."

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP